Induct AS (OSL: INDCT)
Norway
· Delayed Price · Currency is NOK
4.740
-0.120 (-2.47%)
At close: Jan 20, 2025
Induct AS Revenue
Induct AS had revenue of 4.19M NOK in the quarter ending September 30, 2024, a decrease of -22.84%. This brings the company's revenue in the last twelve months to 18.53M, down -10.39% year-over-year. In the year 2023, Induct AS had annual revenue of 21.04M with 8.25% growth.
Revenue (ttm)
18.53M
Revenue Growth
-10.39%
P/S Ratio
6.03
Revenue / Employee
1.03M
Employees
18
Market Cap
111.68M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 21.04M | 1.60M | 8.25% |
Dec 31, 2022 | 19.44M | 5.13M | 35.85% |
Dec 31, 2021 | 14.31M | 2.70M | 23.32% |
Dec 31, 2020 | 11.60M | -2.18M | -15.84% |
Dec 31, 2019 | 13.79M | -1.01M | -6.83% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Nordhealth AS | 513.12M |
Medistim ASA | 541.82M |
Photocure ASA | 526.25M |
Hofseth BioCare ASA | 248.08M |
Vistin Pharma ASA | 426.52M |
Nykode Therapeutics AS | 46.02M |
Omda AS | 419.59M |
ArcticZymes Technologies ASA | 110.76M |